DWTX Dogwood Therapeutics (DWTX) Q4 Loss Narrows to $0.26, Beats Estimates 6 hours ago Dogwood Therapeutics posts Q4 loss of $0.26/share, 69.8% narrower than the $0.86 consensus, as clinical-stage biotech reduces burn rate.